5XRA
Crystal structure of the human CB1 in complex with agonist AM11542
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SLS BEAMLINE X06SA |
Synchrotron site | SLS |
Beamline | X06SA |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2016-12-12 |
Detector | DECTRIS PILATUS3 6M |
Wavelength(s) | 1.0000 |
Spacegroup name | P 21 2 21 |
Unit cell lengths | 66.050, 75.870, 138.900 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 37.910 - 2.800 |
R-factor | 0.235 |
Rwork | 0.234 |
R-free | 0.25190 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 5tgz |
RMSD bond length | 0.003 |
RMSD bond angle | 0.732 |
Data reduction software | XDS |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | PHENIX (1.10.1_2155) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 37.910 | 2.900 |
High resolution limit [Å] | 2.800 | 2.800 |
Rmerge | 0.562 | |
Number of reflections | 16685 | |
<I/σ(I)> | 10.41 | 2.07 |
Completeness [%] | 93.5 | 90.03 |
Redundancy | 6.1 | 4.8 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | LIPIDIC CUBIC PHASE | 293 | 0.1 M sodium cacodylate trihydrate pH 6.4, 300-350 mM C4H4KNaO6, 30% PEG400 |